mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |